Plasma Derivatives

We make use of plasma, the liquid component of blood, for therapeutic purposes and integrate cutting-edge technology platforms with our in-depth knowledge and expertise in plasma technology and scientific research to facilitate the development of new plasma-based and non-plasma treatments.

Our goal is to create novel therapies that meet the unmet medical requirements of individuals suffering from chronic and uncommon diseases that may be fatal. We are committed to helping these individuals with comprehensive treatment that enhance their quality of life.


These are proteins that are produced by the immune system to help fight off infections. Immunoglobulins can be isolated from plasma and used to treat a variety of conditions, including primary and secondary immunodeficiencies, autoimmune disorders, and some neurological disorders.

Coagulation factors

These are proteins that are involved in the blood clotting process. Coagulation factors can be isolated from plasma and used to treat bleeding disorders such as hemophilia.


This is a protein that is synthesized in the liver and is important for maintaining the osmotic pressure of the blood and transporting various substances in the bloodstream. Albumin can be isolated from plasma and used to treat conditions such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns.

Live Saving Plasma

Plasma, which contains proteins and other medicinal substances in the blood, is a vital component. We create therapies from this essential life fluid for individuals all around the world to treat a variety of medical conditions. Plasma is an important component of blood that includes proteins and other therapeutic compounds that can be used to treat a wide range of medical ailments.

We are dedicated to accelerating the development of novel plasma and non-plasma therapeutics by leveraging our plasma knowledge and innovative technology. Our R&D efforts are focused on discovering new compounds and medicines that can assist address unmet medical needs and enhance patient outcomes